Details of the Drug Combinations

General Information of This Drug (ID: DMNST69)

Drug Name

Metaiodobenzylguanidine I-131 DMNST69

Synonyms

Azedra (TN)

Indication

Disease Entry	ICD 11	Status	REF
Neuroblastoma	2D11.2	Phase 2	[1]
Neuroendocrine cancer	2B72.1	Phase 2	[2]
Pheochromocytoma	5A75	Application submitted	[3]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Enzalutamide + Metaiodobenzylguanidine I-131	DCE8HWE	Enzalutamide	Metastatic Prostate Cancer	[4]
------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004852)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	ClinicalTrials.gov (NCT03939689) Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone